Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 17, Issue 45, 2011, Pages 4952-4959

  Minami, Yasunori ^a   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dynamic contrast enhanced ultrasound; Hepatocellular carcinoma; Percutaneous ethanol injection; Radiofrequency ablation

Indexed keywords

ALCOHOL; FLUOROCARBON; PERFLUBUTANE; PERFLUTREN; SHU 508; SONOVUE; SULFUR HEXAFLUORIDE;

ABLATION THERAPY; ANGIOGRAPHY; ARTERIOGRAPHY; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; FLUOROSCOPY; HUMAN; LIVER CELL CARCINOMA; MICROBUBBLE; MICROWAVE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; REVIEW; ULTRASOUND; VASCULARIZATION;

EID: 83155177115     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i45.4952     Document Type: Review

References (72)

1. Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010; 51: 1284-1290
2. Rust C, Gores GJ. Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis 2001; 5: 161-173
3. Lee WS, Yun SH, Chun HK, Lee WY, Kim SJ, Choi SH, Heo JS, Joh JW, Choi D, Kim SH, Rhim H, Lim HK. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 2008; 42: 945-949
4. Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 2008; 25: 445-460
5. Bartolozzi C, Lencioni R. Ethanol injection for the treatment of hepatic tumours. Eur Radiol 1996; 6: 682-696
6. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 323-328
7. McGhana JP, Dodd GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001; 176: 3-16
8. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62 Suppl 1: 64-68
9. Gillams AR. Radiofrequency ablation in the management of liver tumours. Eur J Surg Oncol 2003; 29: 9-16
10. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78 Suppl 1: 113-124
11. Cioni D, Lencioni R, Rossi S, Garbagnati F, Donati F, Cro-cetti L, Bartolozzi C. Radiofrequency thermal ablation of he-patocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001; 177: 783-788
12. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shio-zaki H. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004; 183: 153-156
13. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19: 297-309
14. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol 2001; 11 Suppl 3: E15-E26
15. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007; 33: 1515-1526
16. Furuse J, Nagase M, Ishii H, Yoshino M. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003; 76: 385-392
17. Xia Y, Kudo M, Minami Y, Hatanaka K, Ueshima K, Chung H, Hagiwara S, Inoue T, Ishikawa E, Kitai S, Takahashi S, Tatsumi C, Ueda T, Hayaishi S, Maekawa K. Response evaluation of transcatheter arterial chemoembolization in hepa-tocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography. Oncology 2008; 75 Suppl 1: 99-105
18. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Chung H, Kawasaki T, Maekawa K. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221: 721-730
19. Meloni MF, Goldberg SN, Livraghi T, Calliada F, Ricci P, Rossi M, Pallavicini D, Campani R. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001; 177: 375-380
20. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshi-da H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chaw-la YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474
21. Minami Y, Kudo M, Kawasaki T, Kitano M, Chung H, Maekawa K, Shiozaki H. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 180: 703-708
22. Kudo M, Minami Y. Radiofrequency ablation therapy under harmonic imaging guidance for the recurring cancer after local therapy for HCC: a randomized controlled study with RFA under B-mode guidance. Ultrasound Med Biol 2003; 29: 145
23. Minami Y, Kudo M. Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocel-lular carcinoma. World J Radiol 2009; 1: 86-91
24. Tremosini S, Bruix J. Diagnosis of early hepatocellular carcinoma: ideal goal, but not yet there. Gastroenterology 2011; 140: 358-360
25. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, Zheng SS, Sarin S, Hamid SS, Modawi SB, Fleig W, Fedail S, Thomson A, Khan A, Malfertheiner P, Lau G, Carillo FJ, Krabshuis J, Le Mair A. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010; 44: 239-245
26. Zhang ZM, Guo JX, Zhang ZC, Jiang N, Zhang ZY, Pan LJ. Therapeutic options for intermediate-advanced hepatocel-lular carcinoma. World J Gastroenterol 2011; 17: 1685-1689
27. Forner A, Bruix J. Ablation for hepatocellular carcinoma: Is there need to have a winning technique? J Hepatol 2010; 52: 310-312
28. Schlief R, Schurman R, Niendorf HP. Basic properties and results of clinical trials of ultrasound contrast agents based on galactose. Ann Acad Med Singapore 1993; 22: 762-767
29. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of heman-gioma, hepatocellular carcinoma, and metastasis. Radiology 2000; 215: 153-161
30. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244: 898-906
31. Wang Z, Tang J, An L, Wang W, Luo Y, Li J, Xu J. Contrast- enhanced ultrasonography for assessment of tumor vascu-larity in hepatocellular carcinoma. J Ultrasound Med 2007; 26: 757-762
32. Leen E, Angerson WJ, Yarmenitis S, Bongartz G, Blomley M, Del Maschio A, Summaria V, Maresca G, Pezzoli C, Llull JB. Multi-centre clinical study evaluating the efficacy of So-noVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002; 41: 200-206
33. Kono Y, Lucidarme O, Choi SH, Rose SC, Hassanein TI, Alpert E, Mattrey RF. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after trans-arterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2007; 18: 57-65
34. Ramnarine KV, Kyriakopoulou K, Gordon P, McDicken NW, McArdle CS, Leen E. Improved characterisation of focal liver tumours: dynamic power Doppler imaging using NC100100 echo-enhancer. Eur J Ultrasound 2000; 11: 95-104
35. Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009; 44: 733-741
36. Masuzaki R, Shiina S, Tateishi R, Yoshida H, Goto E, Sugioka Y, Kondo Y, Goto T, Ikeda H, Omata M, Koike K. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26: 759-764
37. von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23: 1557-1568
38. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51 Suppl: S19-S23
39. Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Hepatol Res 2007; 37 Suppl 2: S193-S199
40. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K, Maekawa K. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51 Suppl 1: 61-69
41. Kudo M, Hatanaka K, Maekawa K. Sonazoid-enhanced ultrasound in the diagnosis and treatment of hepatic tumors. J Med Ultrasound 2008; 16: 130-139
42. Kudo M, Hatanaka K, Maekawa K. Defect reperfusion imaing, a newly developed novel technology using Son-azoid in the treatment of hepatocellular carcinoma. J Med Ultrasound 2008; 16: 169-176
43. Hatanaka K, Kudo M, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75 Suppl 1: 42-47
44. Kudo M, Hatanaka K, Maekawa K. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Oncology 2010; 78 Suppl 1: 40-45
45. Numata K, Isozaki T, Ozawa Y, Sakaguchi T, Kiba T, Kubo-ta T, Ito A, Sugimori K, Shirato K, Morimoto M, Tanaka K. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003; 180: 143-149
46. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51: S19-S23
47. Numata K, Morimoto M, Ogura T, Sugimori K, Take-bayashi S, Okada M, Tanaka K. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocel-lular carcinoma lesions not detected by conventional sonog-raphy. J Ultrasound Med 2008; 27: 395-406
48. Maruyama H, Takahashi M, Ishibashi H, Okugawa H, Ok-abe S, Yoshikawa M, Yokosuka O. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultra-sonography. Liver Int 2009; 29: 708-714
49. Miyamoto N, Hiramatsu K, Tsuchiya K, Sato Y, Terae S, Shirato H. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection. Jpn J Radiol 2009; 27: 185-193
50. Minami Y, Kudo M, Hatanaka K, Kitai S, Inoue T, Hagiwara S, Chung H, Ueshima K. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int 2010; 30: 759-764
51. Miyamoto N, Hiramatsu K, Tsuchiya K, Sato Y. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography. J Clin Ultrasound 2010; 38: 339-345
52. Minami Y, Kudo M, Chung H, Kawasaki T, Yagyu Y, Shimono T, Shiozaki H. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007; 188: 489-494
53. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol 2004; 182: 1224-1226
54. Laspas F, Sotiropoulou E, Mylona S, Manataki A, Tsagouli P, Tsangaridou I, Thanos L. Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications. J Gastrointestin Liver Dis 2009; 18: 323-328
55. Park BJ, Byun JH, Jin YH, Won HJ, Shin YM, Kim KW, Park SJ, Kim PN. CT-guided radiofrequency ablation for hepato-cellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol 2009; 20: 490-499
56. Toyoda M, Kakizaki S, Horiuchi K, Katakai K, Sohara N, Sato K, Takagi H, Mori M, Nakajima T. Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol 2006; 12: 608-611
57. Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe J. CT-guided treatment of ultrasonically invisible hepatocel-lular carcinoma. Am J Gastroenterol 2000; 95: 2102-2106
58. Takayasu K, Muramatsu Y, Asai S, Muramatsu Y, Kobayas-hi T. CT fluoroscopy-assisted needle puncture and ethanol injection for hepatocellular carcinoma: a preliminary study. AJR Am J Roentgenol 1999; 173: 1219-1224
59. Maeda T, Hong J, Konishi K, Nakatsuji T, Yasunaga T, Yamashita Y, Taketomi A, Kotoh K, Enjoji M, Nakashima H, Tanoue K, Maehara Y, Hashizume M. Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system. Surg Endosc 2009; 23: 1048-1053
60. Wu B, Xiao YY, Zhang X, Zhang AL, Li HJ, Gao DF. Magnetic resonance imaging-guided percutaneous cryoablation of hepatocellular carcinoma in special regions. Hepatobiliary Pancreat Dis Int 2010; 9: 384-392
61. de Jode MG, Lamb GM, Thomas HC, Taylor-Robinson SD, Gedroyc WM. MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: technique and early progress. J Hepatol 1999; 31: 347-353
62. Kelekis AD, Terraz S, Roggan A, Terrier F, Majno P, Men-tha G, Roth A, Becker CD. Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results. Eur Radiol 2003; 13: 1100-1105
63. Kim YJ, Raman SS, Yu NC, Lu DS. MR-guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2T open MR system. J Magn Reson Imaging 2005; 22: 566-571
64. Terraz S, Cernicanu A, Lepetit-Coiffe M, Viallon M, Salomir R, Mentha G, Becker CD. Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring. Eur Radiol 2010; 20: 886-897
65. Kudo M, Tomita S, Tochio H, Mimura J, Okabe Y, Kashida H, Hirasa M, Ibuki Y, Todo A. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology 1992; 182: 155-160
66. Imari Y, Sakamoto S, Shiomichi S, Isobe H, Ikeda M, Satoh M, Nawata H. Hepatocellular carcinoma not detected with plain US: treatment with percutaneous ethanol injection under guidance with enhanced US. Radiology 1992; 185: 497-500
67. Chen RC, Liao LY, Wang CS, Chen WT, Wang CK, Li YH, Tu HY, Chen PH. Carbon dioxide-enhanced sonographi-cally guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma. AJR Am J Roentgenol 2003; 181: 1647-1652
68. Miyamoto N, Hiramatsu K, Tsuchiya K, Sato Y. Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: treatment of patients with local progression of hepatocellular carcinoma. Radiat Med 2008; 26: 92-97
69. Numata K, Tanaka K, Kiba T, Matsumoto S, Iwase S, Hara K, Kirikoshi H, Morita K, Saito S, Sekihara H. Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO(2)-enhanced sonography. AJR Am J Roentgenol 2001; 177: 789-798
70. Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hat- anaka K, Ueda T, Hagiwara H, Kitai S, Ueshima K, Fukun-aga T, Shiozaki H. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007; 72 Suppl 1: 111-116
71. Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, Ueshima K, Shiozaki H. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008; 190: W335-W341
72. Okamoto E, Sato S, Sanchez-Siles AA, Ishine J, Miyake T, Amano Y, Kinoshita Y. Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: a prospective pilot study. AJR Am J Roentgenol 2010; 194: 1272-1278